)
Dr. Reddy’s Laboratories (DRREDDY) investor relations material
Dr. Reddy’s Laboratories Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q2FY26 revenue grew 9.8% year-over-year and 3% sequentially, reaching ₹88.1 billion, with broad-based growth across markets except North America, which faced price erosion and lower Lenalidomide sales.
Profit after tax attributable to equity holders was ₹14.4 billion, up 14% year-over-year and 1% sequentially.
Strategic acquisitions, including the NRT and Stugeron portfolios, and new product launches in India, APAC, and EMEA supported growth.
Continued focus on innovation, biosimilars, and consumer healthcare, with key regulatory progress in multiple regions.
ESG achievements included maintaining MSCI ESG rating 'A', improved Sustainalytics risk rating, and LEED Platinum certification for Srikakulam facility.
Financial highlights
Consolidated revenue for Q2FY26 was ₹88.1 billion (₹8,805 crore), up 9.8% year-over-year and 3% sequentially.
EBITDA was ₹23.5 billion (₹2,351 crore), with a margin of 26.7%, up 3% year-over-year and sequentially.
Gross margin was 54.7%, down 492 bps year-over-year, mainly due to lower Lenalidomide sales and price erosion in North America.
Diluted EPS for Q2FY26 was ₹17.25.
Net cash surplus as of September 30, 2025, was ₹27.5 billion (₹2,751 crore).
Outlook and guidance
Management is focused on strengthening core businesses, advancing pipeline assets, and driving operational efficiencies.
Confident in maintaining double-digit growth in ex-US markets over the next 1-2 years, supported by new launches and innovation.
Commitment to restoring EBITDA margins to 25%+ in the next two years, with growth levers including semaglutide, abatacept, and business development.
Emphasis on augmenting organic growth with M&A and in-licensing, and maintaining quality, compliance, and sustainability.
Next Dr. Reddy’s Laboratories earnings date
Next Dr. Reddy’s Laboratories earnings date
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)